SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

RINGOLD GORDON

(Last)

(First)

(Middle)

C/O MAXYGEN, INC.

515 GALVESTON DRIVE

(Street)

REDWOOD CITY

94063

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MAXYGEN INC [ MAXY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2003

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/06/2003		G	V	12,000	D	⁽¹⁾	2,494,813	I	Technogen and Family Trust⁽²⁾
Common Stock	08/27/2003		S		655	D	$12.5	526,076⁽³⁾	I	Gordon Ringold and Tanya Zarucki 1999 Trust
Common Stock	08/27/2003		S		100	D	$12.48	525,976	I	Gordon Ringold and Tanya Zarucki 1999 Trust
Common Stock	08/27/2003		S		2,645	D	$12.47	523,331	I	Gordon Ringold and Tanya Zarucki 1999 Trust
Common Stock	08/27/2003		S		5,100	D	$12.4504	518,231	I	Gordon Ringold and Tanya Zarucki 1999 Trust
Common Stock	08/27/2003		S		300	D	$12.45	517,931	I	Gordon Ringold and Tanya Zarucki 1999 Trust
Common Stock	08/28/2003		S		500	D	$12.5	517,431	I	Gordon Ringold and Tanya Zarucki 1999 Trust
Common Stock	08/28/2003		S		34	D	$12.455	517,397	I	Gordon Ringold and Tanya Zarucki 1999 Trust
Common Stock	08/28/2003		S		3,750	D	$12.45	513,647	I	Gordon Ringold and Tanya Zarucki 1999 Trust
Common Stock								1,396,531⁽⁴⁾	I	Technogen⁽⁵⁾
Common Stock								865⁽⁶⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The disposition had no price as it was a gift.

2. The indirect holding of Dr. Ringold after the indicated transaction included 1,961,574 shares of Maxygen common stock that were held by Technogen Associates, L.P. and 63,198 shares that were held by Technogen Enterprises, L.L.C. Technogen Managers, L.L.C. is the general partner of Technogen Associates , L.P. Dr. Ringold is a Managing Member of Technogen Enterprises, L.L.C. and Technogen Managers, L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in the limited liability companies. Dr. Ringold's indirect holdings also include 470,041 shares held by the Gordon Ringold and Tanya Zarucki 1999 Trust.

3. Includes 5,632 shares of Maxygen common stock received as a pro rata distribution from Technogen Associates L.P. Also includes 51,058 shares received as a pro rata distribution from Technogen Managers, L.L.C., which received the shares as a result of a pro rata distribution from Technogen Associates, L.P. In prior reports (and in footnote 2 hereof), Dr. Ringold reported beneficial ownership of all shares held by Technogen Associates L.P.

4. Excludes 628,241 shares of Maxygen common stock distributed by Technogen Associates L.P. since the transaction reported on line 1 hereof.

5. Consists of 1,333,333 shares of Maxygen common stock held by Technogen Associates, L.P. and 63,198 shares held by Technogen Enterprises, L.L.C. Technogen Managers, L.L.C. is the general partner of Technogen Associates , L.P. Dr. Ringold is a Managing Member of Technogen Enterprises, L.L.C. and Technogen Managers, L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in the limited liability companies.

6. Consists of 865 shares of Maxygen common stock received as a pro rata distribution from Technogen Managers, L.L.C., which received the shares as a result of a pro rata distribution from Technogen Associates, L.P. In prior reports (and in footnote 2 hereof), Dr. Ringold reported indirect beneficial ownership of all shares held by Technogen Associates, L.P.

Remarks:

	Gordon Ringold	08/28/2003
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.